Daniel Arias
Stock Analyst at Stifel Nicolaus
(3.18)
# 2,501
Out of 4,362 analysts
490
Total ratings
44.8%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Maintained: Hold | $60 | $47.51 | +26.29% | 11 | Jun 1, 2026 | |
| A Agilent Technologies | Maintained: Buy | $170 | $137.40 | +23.73% | 26 | May 28, 2026 | |
| GH Guardant Health | Maintained: Buy | $130 | $127.03 | +2.34% | 17 | May 28, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $600 | $473.95 | +26.60% | 31 | May 21, 2026 | |
| MTD Mettler-Toledo International | Rated: Buy | $1,600 → $1,400 | $1,169.32 | +19.73% | 29 | May 18, 2026 | |
| QGEN Qiagen | Rated: Hold | $50 → $36 | $36.45 | -1.23% | 18 | May 18, 2026 | |
| WAT Waters | Maintained: Hold | $380 | $379.77 | +0.06% | 28 | May 18, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 | $1.96 | +308.16% | 6 | May 14, 2026 | |
| MXCT MaxCyte | Maintained: Buy | $4 | $1.20 | +233.33% | 15 | May 13, 2026 | |
| ALMR Alamar Biosciences | Initiated Coverage: Buy | $28 | $20.94 | +33.72% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $6 | $4.84 | +23.97% | 24 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $62.70 | -28.23% | 23 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $50 | $50.85 | -1.67% | 28 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $10 | $8.66 | +15.47% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 | $98.36 | +47.42% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 → $100 | $101.07 | -1.06% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $207 | $121.73 | +70.05% | 31 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $155 | $170.93 | -9.32% | 47 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $8 | $9.07 | -11.80% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 | $178.08 | +46.00% | 26 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $25 | $32.16 | -22.26% | 24 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.72 | +83.82% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.94 | n/a | 9 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.15 | n/a | 13 | Mar 1, 2024 |
Tempus AI
Jun 1, 2026
Maintained: Hold
Price Target: $60
Current: $47.51
Upside: +26.29%
Agilent Technologies
May 28, 2026
Maintained: Buy
Price Target: $170
Current: $137.40
Upside: +23.73%
Guardant Health
May 28, 2026
Maintained: Buy
Price Target: $130
Current: $127.03
Upside: +2.34%
Thermo Fisher Scientific
May 21, 2026
Maintained: Buy
Price Target: $600
Current: $473.95
Upside: +26.60%
Mettler-Toledo International
May 18, 2026
Rated: Buy
Price Target: $1,600 → $1,400
Current: $1,169.32
Upside: +19.73%
Qiagen
May 18, 2026
Rated: Hold
Price Target: $50 → $36
Current: $36.45
Upside: -1.23%
Waters
May 18, 2026
Maintained: Hold
Price Target: $380
Current: $379.77
Upside: +0.06%
Rapid Micro Biosystems
May 14, 2026
Maintained: Buy
Price Target: $8
Current: $1.96
Upside: +308.16%
MaxCyte
May 13, 2026
Maintained: Buy
Price Target: $4
Current: $1.20
Upside: +233.33%
Alamar Biosciences
May 12, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $20.94
Upside: +33.72%
May 11, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $4.84
Upside: +23.97%
May 8, 2026
Rated: Hold
Price Target: $40 → $45
Current: $62.70
Upside: -28.23%
May 7, 2026
Maintained: Hold
Price Target: $65 → $50
Current: $50.85
Upside: -1.67%
May 7, 2026
Rated: Buy
Price Target: $8 → $10
Current: $8.66
Upside: +15.47%
May 7, 2026
Rated: Buy
Price Target: $145
Current: $98.36
Upside: +47.42%
May 6, 2026
Rated: Hold
Price Target: $110 → $100
Current: $101.07
Upside: -1.06%
May 6, 2026
Maintained: Buy
Price Target: $207
Current: $121.73
Upside: +70.05%
May 1, 2026
Maintained: Buy
Price Target: $155
Current: $170.93
Upside: -9.32%
Apr 30, 2026
Maintained: Hold
Price Target: $10 → $8
Current: $9.07
Upside: -11.80%
Apr 22, 2026
Maintained: Buy
Price Target: $260
Current: $178.08
Upside: +46.00%
Mar 2, 2026
Maintained: Buy
Price Target: $20 → $25
Current: $32.16
Upside: -22.26%
Nov 10, 2025
Maintained: Buy
Price Target: $5
Current: $2.72
Upside: +83.82%
Jan 22, 2025
Rated: Hold
Price Target: n/a
Current: $5.94
Upside: n/a
Mar 1, 2024
Maintained: Buy
Price Target: $5
Current: $1.15
Upside: n/a